Outgoing CEO of allergy-focused biotech talks partnering with Nestle to tackle hard-to-spot allergies

Jim Cramer sits down with former Aimmune CEO Stephen Dilly to discuss how the company is fighting the country's most prevalent food allergies.
06:10
Wed, Jun 20 20181:00 PM EST